376596-67-7

Upstream product

• 10056-69-6 2,2,2-trifluoro-N-propylacetamide 
• 253273-90-4 3-[3-(bromomethyl)phenyl]-5-methyl-1,2,4-oxadiazole 

Downstream Products

• 376596-68-8 [3-(5-methyl-1,2,4-oxadiazol-3-yl)benzyl]propylamine 

Relevant academic research and scientific papers

Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia

Novel compounds of the formula I, in which R, R1 and R2 are as defined in patent claim 1, are inhibitors of coagulation factor Xa and VIIa and can be employed for the treatment of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexis, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases.

Carbamic acid esters as inhibitors of factor xa

Novel compounds of the formula I in which R, R1 and R2 are as defined in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic illnesses.